Kerala: ENT doctor proposes to combat COVID via glucose liquid

The doctor Dr E Sukumaran said, putting two drops of glucose liquid in the nose, twice a day will be very effective for resisting Coronavirus.

Published On 2020-10-16 03:45 GMT   |   Update On 2020-10-16 07:12 GMT

Kozhikode: An ENT doctor from Koyilandy near here has come out with a new proposal for combating the COVID-19 virus.

The doctor Dr E Sukumaran said, putting two drops of glucose liquid in the nose, twice a day will be very effective for resisting Coronavirus. The liquid should have 25 percent of glucose content in it.

Also Read: Breaking: Oxford Scientists come up with 5 minutes coronavirus antigen Test

Having no side effects, the glucose will destroy the virus, which according to the doctor will remain in the upper part of the human nose for a few days before entering a human body.

Also Read: Private Hospitals can't charge patients for beds twice like hotels: WBCERC

Tags:    
Article Source : UNI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News